Aggressive Natural Killer Cell Leukemia: Is Epstein-Barr Virus Negativity an Indicator of a Favorable Prognosis?

Publisher： Karger

E-ISSN： 1421-9662|120|4|199-206

ISSN： 0001-5792

Source： Acta Haematologica, Vol.120, Iss.4, 2009-01, pp. : 199-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monomorphic Agranular Natural Killer Cell Lymphoma/Leukemia with No Epstein-Barr Virus Association

By  

Acta Haematologica, Vol. 101, Iss. 4, 1999-07 ,pp. : 206-208

Karger

Access to resources Recommend Favorite

Systemic Epstein–Barr virus‐negative mature natural killer‐cell lymphoma with cutaneous and visceral involvement

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 11, 2015-11 ,pp. : 990-992

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Epstein–Barr virus and the pathogenesis of lymphoma

By  

THE JOURNAL OF PATHOLOGY, Vol. 235, Iss. 2, 2015-01 ,pp. : 312-322

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epstein‐barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 8, Iss. 3, 1971-11 ,pp. : 475-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Late‐onset Epstein–Barr virus‐related disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation is associated with impaired early recovery of T and B lymphocytes

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 902-0063, Iss. 10, 2015-10 ,pp. : 904-910

John Wiley & Sons Inc

Access to resources Recommend Favorite